The Million Anesthesia Cases Study (MACS) - a Cohort Study of Preoperative Fasting and Perioperative Outcomes
MACS
1 other identifier
observational
1,200,000
1 country
1
Brief Summary
Perioperative fasting has historically been viewed as a low-risk intervention. However, preliminary data indicate that perioperative loss of nutrition and fluids is likely harmful. This study intends to characterize perioperative fasting practices and their potential effects on clinical outcomes through possible effects on patient well-being (anxiety, hunger, thirst), physiology (hypovolemia, hypotension), perioperative aspiration, etc. The research team hypothesized that in addition to known adverse effects on patients' well-being, prolonged preoperative fasting adversely affects circulating blood volume-related (hypotension, decreased urine output etc.) and glucose metabolism-related (e.g., hypo/hyperglycemia) perioperative physiology. The investigators will also test for an association between the duration of preoperative fasting and the risk of perioperative pulmonary aspiration. Additional knowledge on the potential adverse effects of preoperative fasting will inform preoperative fasting policies and research interventions that are relevant to hundreds of millions of patients subjected to preoperative/preprocedural fasting worldwide each year.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2016
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2016
CompletedFirst Submitted
Initial submission to the registry
June 6, 2025
CompletedFirst Posted
Study publicly available on registry
June 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2030
April 8, 2026
March 1, 2026
13 years
June 6, 2025
April 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Postoperative nausea and vomiting (PONV)
The co-primary outcome of PONV is defined as administration ≥ 1 antiemetic drug within 12 h postoperatively.
12 hours postoperatively
Intraoperative hypotension
The co-primary outcome of intraoperative hypotension is defined as an area under the curve of intraoperative mean arterial pressure \<65 mm Hg.
Intraoperative period.
Perioperative acute kidney injury (AKI)
The co-primary outcome of perioperative AKI is defined as stage 1 or higher, based on Kidney Disease Improving Global Outcomes criteria (creatinine rise ≥ 0.3 mg/dl within 48 h or ≥ 1.5 times baseline) from postoperative day (POD) 0 until POD 7
Postoperative days 0 to 7
Secondary Outcomes (6)
Incidence of prolonged preoperative fasting for clear liquids
48 hours preoperatively
Severity of prolonged clear liquid fasting
48 hours preoperatively
Perioperative hypoglycemia
12 hours preoperatively to 24 hours postoperatively
Perioperative hyperglycemia
12 hours preoperatively to 24 hours postoperatively
Perioperative AKI stage 2 or higher.
Postoperative days 0 to 7
- +1 more secondary outcomes
Other Outcomes (1)
Safety outcome: Perioperative pulmonary aspiration
Intraoperative period to 24 hours postoperatively
Study Arms (1)
Patients who receive anesthesia care
Interventions
This cohort study assesses the duration of preoperative fasting and its clinical effects
Eligibility Criteria
We will include all anesthesia cases at participating institutions.
You may qualify if:
- Diagnostic or therapeutic procedure with anesthesia care (general anesthesia, regional anesthesia, sedation, or a combination of the above)
You may not qualify if:
- Not receiving anesthesia care
- Lack of medical record data in Epic electronic medical record system
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mass General Brigham Hospital Network of secondary, tertiary, and quaternary care hospitals
Boston, Massachusetts, 02114, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Physician-Investigator
Study Record Dates
First Submitted
June 6, 2025
First Posted
June 15, 2025
Study Start
January 1, 2016
Primary Completion (Estimated)
December 31, 2028
Study Completion (Estimated)
December 31, 2030
Last Updated
April 8, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share